| Authors: |
Dubai MA; Department of Neurology, Otto von Guericke University, Magdeburg, Germany., Rebello MV; Department of Neurology, Otto von Guericke University, Magdeburg, Germany., Neumann K; Department of Neurology, Otto von Guericke University, Magdeburg, Germany., Berisha M; Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany., Katsaros D; Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany., Haage TR; Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany., Walther D; Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany., Kaufmann J; Department of Neurology, Otto von Guericke University, Magdeburg, Germany., Fricke S; Institute for Clinical Immunology and Cell Therapeutics, Otto von Guericke University, Magdeburg, Germany; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Magdeburg Center for Cell and Immune Therapy (MAZI), Otto von Guericke University, Magdeburg, Germany., Uher D; Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University, Magdeburg, Germany., Speck O; Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany., Engel J; Department of Neurology, Otto von Guericke University, Magdeburg, Germany., Meuth SG; Department of Neurology, University Hospital Muenster, Muenster, Germany., Melekh B; Department of Neuroradiology, Otto von Guericke University, Magdeburg, Germany., Behme D; Department of Neuroradiology, Otto von Guericke University, Magdeburg, Germany., Mattern H; Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany., Henneicke S; Department of Neurology, Otto von Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany., Schreiber S; Department of Neurology, Otto von Guericke University, Magdeburg, Germany; Magdeburg Center for Cell and Immune Therapy (MAZI), Otto von Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany., Mougiakakos D; Department of Hematology, Oncology, Cell Therapy, and Radiation Therapy, Otto von Guericke University, Magdeburg, Germany; Magdeburg Center for Cell and Immune Therapy (MAZI), Otto von Guericke University, Magdeburg, Germany. Electronic address: dimitrios.mougiakakos@med.ovgu.de. |
